LA Act 76, Controlled Substances Series: Prescribing, Diversion Prevention and Addiction

Prescribing controlled substances for pain and other conditions is a major focus of both the medical community and legislatures throughout the country. The consequences of the use and abuse of controlled substances are frequently in the news. La. R.S. 40:978.3 requires new prescribers of controlled substances to complete a one-time, three-hour continuing education program on best practices for prescribing, drug diversion prevention, and appropriate treatment for addiction prior to licensure from the Board of Pharmacy. This course includes separate sections on each of these topics along with the appropriate laws to meet the Louisiana requirements. 

Learning Objectives

Upon completion, participants should be able to:

  1. Perform comprehensive patient assessments, including additional assessments when considering opioids within the treatment plan.
  2. Utilize multimodal treatment options instead of or in addition to pharmacological strategies, especially when treating pain.
  3. Implement safeguards to prevent and detect diversion of controlled substances, including the use of the prescription drug monitoring program. 
  4. Identify risk for substance misuse and abuse.
  5. Provide referral or treatment for patients with substance use disorders.

Additional Information

Partner: 
Medical Interactive Community
State Approved: 
Louisiana
Course summary
Available credit: 
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC
Course opens: 
02/10/2024
Course expires: 
02/09/2027
Cost:
$225.00
Rating: 
0

Available Credit

  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC

Price

Cost:
$225.00
Please login or register to take this course.

This course is offered through Medical Interactive Community. 

 

To take this course you will be redirected to Medical Interactive Community's website. You must login or create an account with Medical Interactive Community in order to complete this activity. 

 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!